Converge ICT Solutions Inc. partners with the Danao City government to deploy high-capacity internet infrastructure, aiming ...

Converge, a performance‑driven marketing and brand stewardship agency, today announced a new integrated marketing engagement with mea Platform (“mea”), an AI‑native insurance technology company ...

Converge are about to release their second album of 2026. Just months after the February release of Love Is Not Enough, their first non-collaborative album in eight years, the Boston metalcore band ...

File this one under ‘if there’s smoke, there’s fire’, but it’s looking like Converge isn’t done releasing new music. Just a little more than a month after the release of their latest album Love Is Not ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Vision changes can happen for a number of reasons, some of which are no major cause for concern, such as dry eye or fatigue. But others are serious enough to warrant a trip to the emergency department ...

What if you could transform complex images into actionable insights with just a few clicks? That’s exactly what Google Gemini 3’s Agentic Vision promises to deliver, an innovative way to analyze, ...

Converge are back with their first "core-four" studio album since 2017 and singer Jacob Bannon spoke with Full Metal Jackie on her weekend radio show about the band's long awaited return with Love Is ...

Vision boards are often talked about as something creative and inspirational. That can be true, but they can also be a highly practical and motivating tool. A well-designed vision board is not just a ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up ...

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...